NcRNA | Conclusion | Cohort | References |
---|---|---|---|
MiR-221 | MiR-21 expression correlated with poor prognosis in HNSCC patients | 147 HNSCC, including 31 OPSCC | [151] |
Let-7d | Reduced expression of let-7d and miR-205 is a significant predictor of HNSCC progression independent of anatomical site, tumor stage, treatment, or HPV | 104 HNSCC, including 32 OPSCC | [175] |
MiR-205 | |||
MiR-107 | Associated with overall survival (OS), independent of HPV status | 88 OPSCC | [169] |
MiR-151 | |||
MiR-492 | |||
MiR-20b | Associated with disease-free survival, independent of HPV status | ||
MiR-107 | |||
MiR-151 | |||
MiR-182 | |||
MiR-361 | |||
MiR-151 | Associated with distant metastasis, independent of HPV status | ||
MiR-152 | |||
MiR-324-5p | |||
MiR-361 | |||
MiR-492 | |||
MiR-9 | Associated with OS in HPV-positive patients | 150 OPSCC | [168] |
MiR-18a | |||
MiR-31 | |||
MiR-155 | |||
MiR-223 | |||
MiR-146 | Single nucleotide polymorphisms in these miRNAs were associated with reduced and increased risk of OPSCC recurrence, respectively | 1008 OPSCC | [176] |
MiR-196 | |||
MiR-193b-3p | Positively associated with OS | 81 OPSCC obtained from “The Cancer Genome Atlas”, and 95 OPSCC patients included for validation | [177] |
MiR-455-5p | |||
MiR-92a-3p | Negatively associated with OS | ||
MiR-497-5p | |||
PiR-30506 | Associated with OS in HPV-positive patients | 498 non-malignant and HNSCC tissues, including 66 OPSCC | [156] |
PiR-35953 | |||
PiR-36715 | |||
PiR-36984 | |||
PiR-39592 |